Research Topics
| Michael E BrierSummaryAffiliation: University of Louisville Country: USA Publications
|
Detail Information
Publications
Predictive modeling for improved anemia management in dialysis patientsMichael E Brier
Robley Rex Veterans Administration Medical Center, Louisville, Kentucky, USA
Curr Opin Nephrol Hypertens 20:573-6. 2011....
Randomized trial of model predictive control for improved anemia managementMichael E Brier
Department of Veterans Affairs, Louisville, Kentucky, USA
Clin J Am Soc Nephrol 5:814-20. 2010..Variable hemoglobin (Hb) response to erythropoiesis stimulating agents may result in adverse outcomes. The utility of model predictive control for drug dosing was previously demonstrated...
Pharmacokinetics of linezolid in subjects with renal dysfunctionMichael E Brier
University of Louisville, Department of Veterans Affairs, Louisville, Kentucky 40202, USA
Antimicrob Agents Chemother 47:2775-80. 2003..We conclude that no adjustment of the linezolid dosage is needed in subjects with renal dysfunction or subjects on hemodialysis...
Prediction of delayed renal allograft function using an artificial neural networkMichael E Brier
Department of Veterans Affairs, 800 Zorn Avenue, Louisville, KY 40206, USA
Nephrol Dial Transplant 18:2655-9. 2003..In this study, an artificial neural network was used to predict the occurrence of DGF and compared with traditional logistical regression models for prediction of DGF...
Using clinical information in goal-oriented learningAdam E Gaweda
Department of Medicine, Division of Nephrology, University of Louisville, Louisville, KY 40292, USA
IEEE Eng Med Biol Mag 26:27-36. 2007..Furthermore, we have observed that it has a potential to provide even more stable anemia management than the AMP...
Model predictive control of erythropoietin administration in the anemia of ESRDAdam E Gaweda
Division of Nephrology, University of Louisville, Louisville, KY 40202, USA
Am J Kidney Dis 51:71-9. 2008..Variable hemoglobin (Hb) response to erythropoiesis-stimulating agents (ESAs) may result in adverse outcomes. New methods are needed to determine the appropriate dose of ESA to maintain the target Hb level...
Individualization of pharmacological anemia management using reinforcement learningAdam E Gaweda
Department of Medicine, University of Louisville, Louisville, KY 40292, USA
Neural Netw 18:826-34. 2005..Presented results illustrate the ability of the proposed method to achieve the therapeutic goal for individuals with different response characteristics and its potential to become an alternative to currently used techniques...
Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic responseAdam E Gaweda
University of Louisville, Department of Medicine, Division of Nephrology, 615 South Preston Street, Louisville, KY 40202, USA
Clin J Am Soc Nephrol 5:576-81. 2010....
Determining optimum hemoglobin sampling for anemia management from every-treatment dataAdam E Gaweda
University of Louisville, Department of Medicine, Louisville, KY 40202, USA
Clin J Am Soc Nephrol 5:1939-45. 2010..We prospectively analyzed short-term Hb variability and quantified the relationship between frequency of Hb monitoring and error in Hb estimation...
Model predictive control with reinforcement learning for drug delivery in renal anemia managementAdam E Gaweda
Department of Medicine, University of Louisville, Louisville, KY 40292, USA
Conf Proc IEEE Eng Med Biol Soc 1:5177-80. 2006..We describe a method, combining model predictive control for simulation of patient response and reinforcement learning for estimation of dosing strategy, to facilitate the management of anemia due to kidney failure...
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patientsMichael L Merchant
Department of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
Kidney Int 79:546-54. 2011..Thus, two measurable biomarkers of the response to erythropoietic-stimulating agents are present in the serum of treated patients...
Pharmacokinetics of dexrazoxane in subjects with impaired kidney functionMichael E Brier
Department of Veterans Affairs and Division of Nephrology, University of Louisville, Louisville, Kentucky, USA
J Clin Pharmacol 51:731-8. 2011..Modeling study results suggested that equivalent exposure could be achieved if dosing was halved in subjects with CL(CR) less than 40 mL/min compared with controls...
Pharmacodynamic population analysis in chronic renal failure using artificial neural networks--a comparative studyAdam E Gaweda
Kidney Disease Program, University of Louisville, Louisville, KY 40202, USA
Neural Netw 16:841-5. 2003..Applied in a clinical environment, such models will allow for prediction of patient response to the drug at the effect site and, subsequently, for adjusting the dosing regimen...
Comparison of urea reduction ratio and hematocrit data reported in different data systems: results from the Centers for Medicare & Medicaid Services and the Renal Network IncDiane L Frankenfield
Center for Beneficiary Choices Centers for Medicare and Medicaid Services, Baltimore, MD, USA
Am J Kidney Dis 41:433-41. 2003..Urea reduction ratio (URR) and hematocrit values reported on the Centers for Medicare & Medicaid Services (CMS) claims were compared with data from two different databases...
